Biogen (BIIB) October IV elevated

Biogen (NASDAQ: BIIB) September option implied volatility is at 55, October is at 81; compared to its 52-week range 29 to 73 into topline phase 3 data for Alzheimer's drug lecanemab.

You May Also Be Interested In

• Zoetis (ZTS) 1500 contracts of June 85 calls and 1800 contracts of July 80 calls amid cattle screwworm headlines
• Alliance Resource Partners (ARLP) call put ratio 12.5 calls to 1 put with a focus on December 40 calls
• EchoStar Corp. (SATS) call put ratio 2.9 calls to 1 put as share price down 5%